| Ident. | Authors (with country if any) | Title |
|---|
| 000002 (2020) |
Charlotte Girard-Guyonvarc'H ; Michele Iudici | [Targeted therapies for connective tissue diseases and vasculitis]. |
| 000253 (2019) |
Lianne Kearsley-Fleet [Royaume-Uni] ; Sunil Sampath [Royaume-Uni] ; Liza J. Mccann [Royaume-Uni] ; Eileen Baildam [Royaume-Uni] ; Michael W. Beresford [Royaume-Uni] ; Rebecca Davies [Royaume-Uni] ; Diederik De Cock [Royaume-Uni] ; Helen E. Foster [Royaume-Uni] ; Taunton R. Southwood [Royaume-Uni] ; Wendy Thomson [Royaume-Uni] ; Kimme L. Hyrich [Royaume-Uni] | Use and effectiveness of rituximab in children and young people with juvenile idiopathic arthritis in a cohort study in the United Kingdom. |
| 000281 (2019) |
G. Novi [Italie] ; M. Gastaldi [Italie] ; D. Franciotta [Italie] ; G. Pesce [Italie] ; L. Benedetti [Italie] ; A. Uccelli [Italie] | Tocilizumab in MOG-antibody spectrum disorder: a case report. |
| 000307 (2019) |
Francesco Ursini [Italie] ; Piero Ruscitti [Italie] ; Giacomo Pietro Ismaele Caio [Italie] ; Roberto Manfredini [Italie] ; Roberto Giacomelli [Italie] ; Roberto De Giorgio [Italie] | The effect of non-TNF-targeted biologics on vascular dysfunction in rheumatoid arthritis: A systematic literature review. |
| 000350 (2019) |
Kathrine Lederballe Gr N [Oman] ; Elizabeth V. Arkema [Suède] ; Bente Glintborg [Danemark] ; Frank Mehnert [Danemark] ; Mikkel Stergaard [Danemark] ; Lene Dreyer [Danemark] ; Mette N Rgaard [Danemark] ; Niels Steen Krogh [Danemark] ; Johan Askling [Suède] ; Merete Lund Hetland [Danemark] | Risk of serious infections in patients with rheumatoid arthritis treated in routine care with abatacept, rituximab and tocilizumab in Denmark and Sweden. |
| 000371 (2019) |
Tomoyuki Mutoh [Japon] ; Tomonori Ishii [Japon] ; Tsuyoshi Shirai [Japon] ; Kanae Akita [Japon] ; Yukiko Kamogawa [Japon] ; Yoko Fujita [Japon] ; Hiroko Sato [Japon] ; Yuko Shirota [Japon] ; Hiroshi Fujii [Japon] ; Hideo Harigae [Japon] | Refractory Takayasu arteritis successfully treated with rituximab: case-based review. |
| 000382 (2019) |
Diederik De Cock [Belgique] ; Patrick Verschueren [Belgique] | Primus inter pares: the choice of biologic drugs in rheumatoid arthritis. |
| 000413 (2019) |
Masayoshi Harigai [Japon] ; Michi Tsutsumino [Japon] ; Hideto Takada [Japon] ; Kenji Nagasaka [Japon] | Molecular targeted therapies for microscopic polyangiitis and granulomatosis with polyangiitis. |
| 000452 (2019) |
Sakiko Tabata [Japon] ; Tomoaki Higuchi [Japon] ; Seishiro Tatsukawa [Japon] ; Kazuyuki Narimatsu [Japon] ; Hiroaki Takeo [Japon] ; Susumu Matsukuma [Japon] ; Toshimitsu Ito [Japon] | Idiopathic Multicentric Castleman Disease with Autoimmune Hemolytic Anemia and Production of Anti-drug Antibody against Tocilizumab. |
| 000518 (2019) |
Sofia Kourkounti [Grèce] ; Vasilios Paparizos [Grèce] ; Theodoros Retsas [Grèce] ; Amerini Dimitrakopoulou [Grèce] ; Dimitrios Rigopoulos [Grèce] | Cutaneous vasculitis in HIV-associated Castleman's disease: a rare manifestation. |
| 000520 (2019) |
Natalia Genere [États-Unis] ; Marius N. Stan [États-Unis] | Current and Emerging Treatment Strategies for Graves' Orbitopathy. |
| 000522 (2019) |
Saara Huoponen [Finlande] ; Kalle J. Aaltonen [Finlande] ; Jaana Viikinkoski [Finlande] ; Jarno Rutanen [Finlande] ; Heikki Relas [Finlande] ; Kirsi Taimen [Finlande] ; Kari Puolakka [Finlande] ; Dan Nordström [Finlande] ; Marja Blom [Finlande] | Cost-effectiveness of abatacept, tocilizumab and TNF-inhibitors compared with rituximab as second-line biologic drug in rheumatoid arthritis. |
| 000533 (2019) |
Jacques-Eric Gottenberg [France] ; Jacques Morel [France] ; Elodie Perrodeau [France] ; Thomas Bardin [France] ; Bernard Combe [France] ; Maxime Dougados [France] ; Rene-Marc Flipo [France] ; Alain Saraux [France] ; Thierry Schaeverbeke [France] ; Jean Sibilia [France] ; Martin Soubrier [France] ; Olivier Vittecoq [France] ; Gabriel Baron [France] ; Arnaud Constantin [France] ; Philippe Ravaud [France] ; Xavier Mariette [France] | Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study. |
| 000535 (2019) |
Alexandre Virone [France] ; Jean-Philippe Bastard [France] ; Soraya Fellahi [France] ; Jacqueline Capeau [France] ; Stéphanie Rouanet [France] ; Jean Sibilia [France] ; Philippe Ravaud [France] ; Francis Berenbaum [France] ; Jacques-Eric Gottenberg [France] ; Jérémie Sellam [France] | Comparative effect of tumour necrosis factor inhibitors versus other biological agents on cardiovascular risk-associated biomarkers in patients with rheumatoid arthritis. |
| 000536 (2019) |
Thomas Frisell [Suède] ; Johan Askling [Suède] | Comment on: Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register: reply. |
| 000537 (2019) |
Thomas Frisell [Suède] ; Johan Askling [Suède] | Comment on: Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register: reply. |
| 000538 (2019) |
Hasan Sat ; Gülce Ecem Can [Turquie] ; Reyhan Bilici Salman ; Asl Han Avano Lu Güler ; Hazan Karadeniz ; Abdurrahman Tufan | Comment on: Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register. |
| 000539 (2019) |
Andrew N B. Weil [Royaume-Uni] | Comment on: Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from a nationwide Swedish register. |
| 000540 (2019) |
Roberto Padoan [Italie] ; Diego Cazzador [Italie] ; Alfonso Luca Pendolino [Italie] ; Mara Felicetti [Italie] ; Susanna De Pascalis [Italie] ; Elisabetta Zanoletti [Italie] ; Roberto Bovo [Italie] ; Alessandro Martini [Italie] ; Franco Schiavon [Italie] | Cogan's syndrome: new therapeutic approaches in the biological era. |
| 000565 (2019) |
Akshay S. Thomas [États-Unis] | Biologics for the treatment of noninfectious uveitis: current concepts and emerging therapeutics. |
| 000594 (2018) |
C. Fiehn [Allemagne] ; L. Unger [Allemagne] ; H. Schulze-Koops [Allemagne] ; F. Proft [Allemagne] ; J C Henes [Allemagne] ; A. Jacobi [Allemagne] ; T. Dörner [Allemagne] | [Rituximab for the treatment of poly- and dermatomyositis : Results from the GRAID-2 registry]. |
